Source: CureToday articles
“For their love, support and kindness, I am eternally grateful and blessed to have such people in our lives,” said Levinson.
Recent Content
- Treatment pattern among patients with relapsed/refractory multiple myeloma (RRMM) who had received pomalidomide-based regimens in Taiwan
- Clinical Perspectives on GPRC5D-Targeted CAR T-Cell Therapy for Multiple Myeloma
- A single-day polychemotherapy regimen with proteasome inhibitor combinations for relapsed/refractory myeloma in the era of novel therapies
- Anaplastic Multiple Myeloma With a Novel Proliferation of Pleomorphic Binuclear Plasma Cells
- Association of Thrombocytopenia With Disease Burden, High-Risk Cytogenetics, and Survival in Newly Diagnosed Multiple Myeloma Patients Treated With Novel Therapies
- R2-ISS staging combined with circulating plasma cells improves risk stratification for newly diagnosed multiple myeloma: a single-center real-world study
- Identification of a novel lactylation-related gene signature predicts the prognosis of multiple myeloma and experiment verification
- Correction: Monoclonal proteinuria predicts progression risk in asymptomatic multiple myeloma with a free light chain ratio 100
- Physical activity and exercise motivation of multiple myeloma patients: a prospective cross-sectional study
- Central nervous system multiple myeloma: A real-world multi-institutional study of the Greek Myeloma Study Group